Medical news update
- Sex Differences in Left Ventricular Remodeling for Aortic Regurgitation
This cohort study evaluates sex differences in left ventricular remodeling among individuals with aortic regurgitation.
- Patient Engagement With Home Blood Pressure Monitoring
This cohort study evaluates patient engagement with home blood pressure monitoring in a remote hypertension management program.
- Sex Differences in Left Ventricular Remodeling and Outcomes in Aortic Regurgitation
Recommendations for aortic valve replacement (AVR) in asymptomatic patients with severe aortic regurgitation (AR) embedded in international practice guidelines have traditionally cited thresholds for […]
- Cardiovascular-Kidney-Metabolic Medication Eligibility
This cohort study evaluates eligibility for cardiovascular-kidney-metabolic medications in Europe and the US.
- Everything Right, Everything Wrong
In this essay, an intern confronts how effort and outcome diverge in unexpected ways during their first shift as a physician.
- Device-Assisted vs Standard Valsalva Maneuver for Terminating Supraventricular Tachycardia
This randomized clinical trial assesses the efficacy of a handheld Valsalva maneuver assist device in improving sinus rhythm restoration rates in patients with supraventricular tachycardia.
- One-Year Outcomes in Heart Failure With Reduced Ejection Fraction
This cohort study evaluates clinical outcomes and health care costs among Medicare patients hospitalized for heart failure with reduced ejection fraction and prescribed quadruple medical therapy at […]
- The Cost-Effectiveness Evolution of Cardiovascular Care
Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) and the glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide represent 2 landmark innovations in cardiometabolic care. […]
- Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation
- Accumulation and attenuation of cardiovascular benefit with glucagon-like peptide 1 receptor agonists
- Accumulation and attenuation of cardiovascular benefit with glucagon-like peptide 1 receptor agonists
- Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation
- Trends and inequalities in advice and guidance versus direct referral in NHS primary care, 2015-23: population based study
- Trends and inequalities in advice and guidance versus direct referral in NHS primary care, 2015-23: population based study
- Effectiveness of non-pharmacological interventions for fatigue in long term conditions: systematic review and network meta-analysis
- Effectiveness of non-pharmacological interventions for fatigue in long term conditions: systematic review and network meta-analysis
- Eosinophilic oesophagitis: pathophysiology, diagnosis, and treatment
- Eosinophilic oesophagitis: pathophysiology, diagnosis, and treatment
- A new era in reducing obesity and the risk of cardiovascular disease events in preeclampsia
No abstract available
- Targeting sympathetic activation in the treatment of hypertension
No abstract available
- Strategies to curb the rising burden of hypertension in sub-Saharan Africa: insights from the WHO global hypertension report 2025
No abstract available
- Does the blood pressure response to renal denervation depend on the degree of sympathetic overactivity?
No abstract available
- Re-evaluating the ‘12-month’ interval for self-monitoring blood pressure: a focus on high-risk populations and dynamic treatment phases
No abstract available
- Reply to correspondence “Re-evaluating the ‘12-month’ interval for self-monitoring BP: a focus on high-risk populations and dynamic treatment phases”
No abstract available
- Family medicine organizations: missing stakeholders in the 2025 ACC/AHA hypertension guideline
No abstract available
- Prospective association between the gut microbiome and incident hypertension: a 20-year cohort study
Introduction: Hypertension remains the leading modifiable risk factor attributable to 10.8 million premature deaths. Hence the study of hypertension and gut microbiome as a therapeutic target is […]
- ESH Hybrid Webinar 2025
NOW AVAILABLE HERE
- ESH Webinars
AVAILABLE HERE SOON
- ESH 2026
INNOVATIONS IN CARDIOMETABOLIC MANAGEMENT February 16 - Late Breaker Submission Opens February 27 - Late Breaker Final Submission March 17 - Early Bird Registration (DEADLINE)
- ESH MASTERplan for Hypertension Management in CKD – webinars
Did you miss the webinar “ESH MASTERplan for Hypertension Management in CKD”? The recording is now available HERE
- Summer School 2026
Date: 6-11 September, 2026 Venue: Lunteren, The Netherlands
- ESH 2024 webinars
Webinar 1: Key Points of the Hypertension Guidelines - The ESH MASTERplan for hypertension Webinar 2: Managing Hypertensive Patients in Clinical Practice – Update on the management of […]
- ESH Webinars 2024
PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies PART 2: Hypertension treatment challenges and options in comorbidities
- ESH 2024
BERLIN MAY 31 - JUNE 3, 2024 www.eshannualmeetings.eu Abstracts are available in Journal of Hypertension
- Prevalence of Hypertension in Venezuela: A Systematic Review and Meta‐Analysis
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure Monitoring
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- TREAT: A Multicentre Cross‐sectional TReatment Evaluation of Apparent Resistant hyperTension in Belgium
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Metformin Alters Exercise Training Induced Blood Pressure and Aortic Waveform Adaptations in Adults at Risk for Metabolic Syndrome
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Accuracy of New Hypertensive Crisis Diagnoses Using International Classification of Disease (ICD)‐10: A Validation Study in a National Medicare Sample
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Comment on “Overnight Dexamethasone in Primary Aldosteronism Screening in Patients on Interfering Therapy (ODEPRASC): A Diagnostic Interpretability Study Protocol”
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Dietary Sodium Reduction Reveals Aldosterone Dysregulation in Patients With Essential Hypertension
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Revealing Sex Differences in Hypertensive Urgency Management: Insights From a Tertiary Hospital
The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
- Prevalence and clinical characteristics of secondary hypertension in young hypertensive tertiary care patients
Journal of Human Hypertension, Published online: 20 March 2026; doi:10.1038/s41371-026-01133-wPrevalence and clinical characteristics of secondary hypertension in young hypertensive tertiary care […]
- A multi-centre study of prescribing patterns for the management of resistant hypertension amongst cardiologists
Journal of Human Hypertension, Published online: 17 March 2026; doi:10.1038/s41371-026-01128-7A multi-centre study of prescribing patterns for the management of resistant hypertension amongst […]
- Blood pressure trends and disparities across the COVID-19 pandemic in a large diverse urban population
Journal of Human Hypertension, Published online: 13 March 2026; doi:10.1038/s41371-026-01130-zBlood pressure trends and disparities across the COVID-19 pandemic in a large diverse urban population
- C-reactive protein and residual cardiovascular risk in hypertension: a prospective cohort study
Journal of Human Hypertension, Published online: 11 March 2026; doi:10.1038/s41371-026-01118-9C-reactive protein and residual cardiovascular risk in hypertension: a prospective cohort study
- 68Ga-Pentixafor PET/CT complements AVS deficiencies in bilateral aldosterone-producing adenomas: Lessons from unexpected sequential partial adrenalectomy
Journal of Human Hypertension, Published online: 10 March 2026; doi:10.1038/s41371-026-01131-y68Ga-Pentixafor PET/CT complements AVS deficiencies in bilateral aldosterone-producing adenomas: Lessons […]
- Association between hemoglobin and all-cause mortality in patients with obstructive sleep apnea and hypertension: insights from an observational study
Journal of Human Hypertension, Published online: 09 March 2026; doi:10.1038/s41371-026-01127-8Association between hemoglobin and all-cause mortality in patients with obstructive sleep apnea and […]
- Professor Adrian James Brendan Brady: 27th May 1961 - 28th January 2026
Journal of Human Hypertension, Published online: 05 March 2026; doi:10.1038/s41371-026-01124-xProfessor Adrian James Brendan Brady: 27th May 1961 - 28th January 2026
- Associations between pulse pressure amplification and inflammation in young adults according to body composition: The African-PREDICT study
Journal of Human Hypertension, Published online: 27 February 2026; doi:10.1038/s41371-026-01126-9Associations between pulse pressure amplification and inflammation in young adults according to body […]
- Posts will be published when available. Sorry for inconvenience